These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38373253)

  • 1. The FDA's proposed rule on laboratory-developed tests: what happens next?
    Genzen JR; Moser KA
    Lab Med; 2024 Mar; 55(2):109-110. PubMed ID: 38373253
    [No Abstract]   [Full Text] [Related]  

  • 2. Amendments to general regulations of the Food and Drug Administration. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2010 Nov; 75(229):73951-5. PubMed ID: 21121182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removal of regulations regarding certification of drugs composed wholly or partly of insulin; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 May; 63(92):26690-3. PubMed ID: 10179340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removal of regulations regarding certification of antibiotic drugs; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 May; 63(91):26127-9. PubMed ID: 10179335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA's proposed rule for the regulation of laboratory-developed tests.
    Miller MB; Watts ML; Samuel L
    J Clin Microbiol; 2024 Feb; 62(2):e0148823. PubMed ID: 38206042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of regulations regarding certification of drugs composed wholly or partly of insulin--FDA. Direct final rule.
    Fed Regist; 1998 May; 63(92):26694-9. PubMed ID: 10179341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Product Development Under FDA's Animal Rule: Understanding FDA's Expectations and Potential Implications for Traditional Development Programs.
    Allio T
    Ther Innov Regul Sci; 2016 Sep; 50(5):660-670. PubMed ID: 30231765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amendment of various device regulations to reflect current American Society for Testing and Material citations. Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 2000 Jan; 65(15):3584-5. PubMed ID: 11010654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical devices; hearing aids; technical data amendments. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Jun; 73(106):31358-60. PubMed ID: 18677822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical devices; reports of corrections and removals--FDA. Direct final rule.
    Fed Regist; 1998 Aug; 63(152):42229-33. PubMed ID: 10181725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical devices; humanitarian use of devices--FDA. Direct final rule.
    Fed Regist; 1998 Apr; 63(74):19185-90. PubMed ID: 10178430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule.
    Fed Regist; 1998 Sep; 63(188):51825-7. PubMed ID: 10185812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the Food and Drug Administration's Jurisdiction Over Laboratory-Developed Tests and Divisions Between Food, Drug, and Cosmetic Act-Regulated and Clinical Laboratory Improvement Amendments of 1988-Regulated Activities.
    Thompson BM; Scott BI; Boiani JA
    Clin Lab Med; 2016 Sep; 36(3):575-85. PubMed ID: 27514469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conforming regulations regarding removal of section 507 of the Federal Food, Drug, and Cosmetic Act; confirmation of effective date. Food and Drug Administration, HHS. Direct final rule; confirmation of effective date.
    Fed Regist; 1999 May; 64(94):26657. PubMed ID: 10558515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality mammography standards. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Direct final rule.
    Fed Regist; 1999 Jun; 64(116):32404-7. PubMed ID: 10558582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--FDA. Direct final rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20530-3. PubMed ID: 10179319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, and distributor reporting--FDA. Direct final rule.
    Fed Regist; 1998 May; 63(91):26069-77. PubMed ID: 10179334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revision to requirements for licensed Anti-Human Globulin and Blood Grouping Reagents. Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 2000 Dec; 65(239):77497-9. PubMed ID: 11503726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.